Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long Non-Coding RNA CRNDE, LINC00957, and AC072061.1 as a Promising Diagnostic and Prognostic Biomarker in Glioblastoma Multiforme. | Iran J Public Health | 2024 | 39429673 | PubTator, text mining | PubMed |
| Response to PARP Inhibition in BARD1-Mutated Refractory Neuroblastoma. | N Engl J Med | 2024 | 39413393 | PubTator, text mining | PubMed |
| The role of SUMOylation in biomolecular condensate dynamics and protein localization. | Cell Insight | 2024 | 39399482 | PubTator, text mining | PubMed |
| Homologous recombination deficiency gene panel analysis results in synchronous endometrial and ovarian cancers. | Rev Assoc Med Bras (1992) | 2024 | 39356959 | PubTator, text mining | PubMed |
| Survival advantage of native and engineered T cells is acquired by mitochondrial transfer from mesenchymal stem cells. | J Transl Med | 2024 | 39334383 | PubTator, text mining | PubMed |
| Identification of ubiquitin markers for survival and prognosis of ovarian cancer. | Heliyon | 2024 | 39315145 | PubTator, text mining | PubMed |
| Promotion of DNA end resection by BRCA1-BARD1 in homologous recombination. | Nature | 2024 | 39261729 | PubTator, text mining | PubMed |
| Mechanism of BRCA1-BARD1 function in DNA end resection and DNA protection. | Nature | 2024 | 39261728 | PubTator, text mining | PubMed |
| Protocol for evaluating the E3 ligase activity of BRCA1-BARD1 and its variants by nucleosomal histone ubiquitylation. | STAR Protoc | 2024 | 39243377 | PubTator, text mining | PubMed |
| Infiltrating Ductal Breast Carcinoma in a Male Patient With Associated BARD1 Mutation. | Cureus | 2024 | 39233942 | PubTator, text mining | PubMed |
| Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer. | JAMA Netw Open | 2024 | 39226054 | PubTator, text mining | PubMed |
| DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes. | JCO Precis Oncol | 2024 | 39178368 | PubTator, text mining | PubMed |
| Response to PARP Inhibition in BARD1-Mutated Refractory Neuroblastoma. | N Engl J Med | 2024 | 39141861 | PubTator, text mining | PubMed |
| Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapy. | Gastric Cancer | 2024 | 39110344 | PubTator, text mining | PubMed |
| Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status. | Breast Cancer Res Treat | 2024 | 39080120 | PubTator, text mining | PubMed |
| Multi-gene panel analysis in BRCA1/2-negative patients suspected of hereditary breast and ovarian cancer syndrome: Real-world data from a single institution. | J Obstet Gynaecol Res | 2024 | 39077936 | PubTator, text mining | PubMed |
| Systematic Review and Meta-Analysis of Lifestyle and Reproductive Factors Associated with Risk of Breast Cancer in Asian Women. | Cancer Epidemiol Biomarkers Prev | 2024 | 39018331 | PubTator, text mining | PubMed |
| Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling. | Proc Natl Acad Sci U S A | 2024 | 38990952 | PubTator, text mining | PubMed |
| Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing. | Ann Oncol | 2024 | 38986768 | PubTator, text mining | PubMed |
| Germline rare variants in HER2-positive breast cancer predisposition: a systematic review and meta-analysis. | Front Oncol | 2024 | 38978731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=11